pvan data analysis software version 3.5 (Millar Inc)
90
Structured Review
Millar Inc
pvan data analysis software version 3.5
Pvan Data Analysis Software Version 3.5, supplied by Millar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pvan+3%2E5/pv+analysis+software+pvan/pm34296331-56-18-24
Average 90 stars, based on 1 article reviews
Pvan Data Analysis Software Version 3.5, supplied by Millar Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pvan+3%2E5/pv+analysis+software+pvan/pm34296331-56-18-24
Average 90 stars, based on 1 article reviews
pvan data analysis software version 3.5 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction. Article Snippet: Although decreased protein kinase G (PKG) activity was proposed as potential therapeutic target in heart failure with preserved ejection fraction (HFpEF), randomized clinical trials (RCTs) with type-5 phosphodiesterase inhibitors (PDE5i) showed neutral results.. Whether specific subgroups of HFpEF patients may benefit from PDE5i remains to be defined.. Our aim was to test chronic sildenafil therapy in the young male ZSF1 obese rat model of HFpEF with severe hypertension and metabolic syndrome. Article Title: ITRAQ-based proteomics reveals the potential mechanism of fluoride-induced myocardial contraction function damage. Article Snippet: Fluorosis is a worldwide public health problem, and its adverse effects on the heart have been confirmed by many studies.. Abnormal myocardial contractions are often associated with impairment of cardiac function as a cause or consequence.. We designed two-part experiments to search for biomarkers and clarify the underlying molecular mechanism of fluoride on myocardial contraction. Article Title: Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction Article Snippet: July 2019 1 BACKGROUND: The interplay between the stiffened heart and vessels has long been viewed as a core mechanism in heart failure with preserved ejection fraction, but the incremental vascular molecular remodeling mechanisms from systemic arterial hypertension to heart failure with preserved ejection fraction remain poorly investigated.. Our aim was to characterize central arterial remodeling and dysfunction in ZSF1 obese rats and to compare it with hypertensive ZSF1 lean and healthy Wistar-Kyoto controls. Article Title: Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome Article Snippet: Signals were continuously acquired ( Article Title: Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction. Article Snippet: Sara Leite,* Sara Rodrigues,* Marta Tavares-Silva, José Oliveira-Pinto, Mohamed Alaa, Mahmoud Abdellatif, Dulce Fontoura, X Inês Falcão-Pires, Thierry C. Gillebert, Adelino F. Leite-Moreira, and X André P. Lourenço Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal; Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Porto, Portugal; Department of Cardiology, Hospital São João, Porto, Portugal; Department of Vascular Surgery, Hospital São João, Porto, Portugal; Department of Cardiothoracic Surgery, Suez Canal University, Ismaileya, Egypt; Department of Cardiology, Ghent University, Ghent, Belgium; Department of Cardiothoracic Surgery, Hospital São João, Porto, Portugal; and Department of Anesthesiology, Hospital São João, Porto, Portugal Article Title: Hemodynamic and Histopathologic Benefits of Early Treatment with Macitentan in a Rat Model of Pulmonary Arterial Hypertension Article Snippet: Analyses of the pressure-volume loops were performed using a commercially available program, |